XIONG ET AL.
9 of 10
was stirred vigorously for 10 min at 80 °C under MW
irradiation (400 W). Then, benzyl azide (0.5 mmol) and
FBPs‐CuBr (5.50 mg, 0.002 mmol Cu) were added into the
reaction system, the mixture was further heated and stirred
under the same conditions until complete consumption of
the starting substrates monitored by TLC. Subsequently, the
reaction mixture was cooled to room temperature and FBPs‐
CuBr was isolated by simple filtration, the residual mixture
was extracted with ethyl acetate (10.0 mL × 3). The combined
organic extracts were washed with saturated brine, and dried
(anhydrous MgSO4). After removal of ethyl acetate under
reduced pressure, the residue was purified by flash chroma-
tography on silica‐gel to give the desired product.
(m, 14H), 6.87–6.86 (m, 2H), 6.77–6.75 (m, 1H), 5.45 (s,
4H), 4.66 (s, 4H); 13C NMR (100 MHz, CDCl3) δ:
134.71, 129.27, 129.08, 128.66, 127.84, 122.00, 54.09,
46.95; MS (ESI): m/z calc. For C25H25N7: 435.22 [M]+,
found: 436.14 [M + H]+.
N,N‐bis((1‐benzyl‐1H‐1,2,3‐triazol‐4‐yl)methyl)(phenyl)
methanamine (Table 2, entry 7): FTIR (KBr disc) cm−1: 3120
(m), 3065 (m), 3041 (w), 2930 (m), 2834 (m), 1494 (m),
1
1434 (s), 1382 (s), 1319 (s), 740 (s), 700 (m); H NMR
(400 MHz, CDCl3) δ: 7.50–7.28 (m, 17H), 5.52 (s, 4H),
3.74 (s, 4H), 3.65 (s, 2H); 13C NMR (100 MHz, CDCl3) δ:
134.85, 129.08, 129.05, 128.66, 128.28, 127.94, 127.04,
123.10, 57.74, 54.08, 47.58; MS (ESI): m/z calc. For
C27H27N7: 449.23 [M]+, found: 450.15[M + H]+.
N,N‐bis((1‐benzyl‐1H‐1,2,3‐triazol‐4‐yl)methyl)butan‐1‐
amine (Table 2, entry 8): FTIR (KBr disc) cm−1: 3136 (s),
3065 (w), 2930 (w), 1597 (s), 1510 (m), 1446 (w), 1367
(m), 1224 (m), 1057 (m), 756 (s), 716 (w); 1H NMR
(400 MHz, CDCl3) δ: 7.52–7.28 (m, 12H), 5.22 (s, 4H),
3.73 (s, 4H), 2.46 (s, 2H), 1.27 (s, 4H), 0.85 (s, 3H); 13C
NMR (100 MHz, CDCl3) δ: 134.85, 129.07, 128.64,
127.95, 122.95, 54.08, 53.34, 47.84, 20.45, 13.95; MS
(ESI): m/z calc. For C24H29N7: 415.25 [M]+, found: 416.15
[M + H]+.
4.4 | Spectroscopic data of the N‐substituted 1,
2, 3‐triazoles
1,4‐bis((1‐benzyl‐1H‐1,2,3‐triazol‐4‐yl)methyl)piperazine
(Table 2, entry 3): FT‐IR (KBr disc) cm−1: 3034 (w), 2940
(w), 2874 (m), 2821 (w), 2803 (w), 2785 (w), 2741 (w),
2692(w), 1639 (m), 1550 (m), 1493 (m), 1457 (m), 1373
(m), 1324 (m), 1284 (m), 1208 (m), 1160 (m), 1128 (m),
1048 (m), 1008 (m), 928 (m), 867 (m), 830 (m), 760 (s);
1H NMR (400 MHz, CDCl3) δ: 7.44–7.37 (m, 12H), 5.52
(s, 4H), 3.70 (s, 4H), 2.59 (s, 8H); 13C NMR (100 MHz,
CDCl3) δ: 134.60, 129.13, 128.76, 128.14, 54.16, 53.15,
52.54; MS (ESI): m/z calc. For C24H28N8: 428.24 [M]+,
found: 429.52 [M + H]+.
4‐((1‐(2‐(2‐(2‐methoxyethoxy)ethoxy)ethyl)‐1H‐1,2,3‐
triazol‐4‐yl)methyl)morpholine (Table 2, entry 9): FTIR
(KBr disc) cm−1: 3137 (w), 2875 (s), 2817 (s), 1977 (w),
1648 (w), 1551 (s), 1453 (m), 1351 (m), 1328 (m), 1284
(w), 1115 (s), 1049 (m), 1004 (m), 915 (m), 862 (w), 800
N‐((1‐benzyl‐1H‐1,2,3‐triazol‐4‐yl)methyl)‐N‐
1
butylbutan‐1‐amine (Table 2, entry 4): FT‐IR (KBr disc) cm
−1: 3144 (w), 3080 (w), 3041 (w), 2953 (s), 2874 (m), 2811
(w), 1470 (s), 1382 (m), 1327 (m), 1216 (m), 1057 (m),
(w), 711 (w); H NMR (400 MHz, CDCl3) δ: 7.70 (s, 1H),
4.54 (t, J = 5.1 Hz, 2H), 3.88 (t, J = 5.1 Hz, 2H), 3.73–
3.71 (m, 4H), 3.68 (s, 2H), 3.63–3.61 (m, 6H), 3.55 (dd,
J = 5.7, 3.2 Hz, 2H), 3.38 (s, 3H), 2.55–2.52 (m, 4H); 13C
NMR (100 MHz, CDCl3) δ: 143.67, 123.95, 71.90, 70.51,
69.47, 66.80, 59.02, 53.61, 53.30, 50.19. MS (ESI): m/z calc.
For C14H26N4O4: 314.20 [M]+, found: 315.45 [M + H]+.
1
724 (s); H NMR (400 MHz, CDCl3) δ: 7.36–7.23 (m, 6H),
5.51 (s, 2H), 3.73 (s, 2H), 2.46–2.33 (m, 4H), 1.42 (dt,
J = 15.0, 7.4 Hz, 4H), 1.30–1.20 (m, 4H), 0.85 (t,
J = 7.3 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ: 146.26,
134.94, 131.99, 130.86, 130.12, 54.04, 53.54, 49.03, 29.21,
20.57, 13.99; MS (ESI): m/z calc. For C18H28N4: 300.23
[M]+, found: 301.53 [M + H]+.
ACKNOWLEDGEMENTS
4‐((1‐benzyl‐1H‐1,2,3‐triazol‐4‐yl)methyl)morpholine
(Table 2, entry 5): FT‐IR (KBr disc) cm−1: 3152 (m), 3096
(w), 3033 (w), 2969 (m), 2850 (m), 2811 (m), 1462 (m),
This work was financially supported by the National Natural
Science Foundation of China (21004024), the Natural
Science Foundation of Fujian province (2016 J01063), the
Program for New Century Excellent Talents in University
of Fujian province (2012FJ‐NCET‐ZR03), the Promotion
Program for Young and Middle‐aged Teacher in Science
and Technology Research of Huaqiao University (ZQN‐
YX103) and Science & Technology Project of Quanzhou
(2014Z126).
1
1335 (m), 1279 (m), 1216 (m), 1130 (s), 732 (m); H NMR
(400 MHz, CDCl3) δ: 7.41–7.28 (m, 6H), 5.53 (s, 2H),
3.79–3.68 (m, 4H), 3.66 (s, 2H), 2.51 (s, 4 H); 13C NMR
(100 MHz, CDCl3) δ: 134.63, 129.13, 128.77, 128.11,
122.56, 66.78, 54.16, 53.70, 53.37; MS (ESI): m/z calc. For
C14H18N4O: 258.15 [M]+, found: 258.86 [M]+.
N,N‐bis((1‐benzyl‐1H‐1,2,3‐triazol‐4‐yl)methyl)
benzenamine (Table 2, entry 6): FTIR (KBr disc) cm−1
:
REFERENCES
3128 (m), 3073 (m), 3041 (w), 2953 (m), 2938 (m), 2866
(w), 2803 (w) 1462 (m), 1327 (s), 1224 (s), 1128 (s), 732
(s), 708 (w); 1H NMR (400 MHz, CDCl3) δ: 7.35–7.28
[1] N. Siddiqui, W. Ahsan, M. S. Alam, R. Ali, S. Jain, B. Azad, J.
Akhtar, Int. J. Pharm. Sci. Rev. Res. 2011, 8, 161.